This report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of the best available TB regimens — as little as one month or once weekly for TB prevention, four months for drug-susceptible TB, and six months for drug-resistant TB — by the end of 2024. The report takes stock of what 1/4/6×24 has accomplished so far since its founding in 2022, and analyzes remaining gaps to be filled to reach its ambitious goal by the end of this year — particularly pertaining to the “4” regimen, for which uptake has been sorely limited and which original modeling shows has the potential to reduce total treatment time by 6.3 million years through 2030. Read the report here.
top of page
Recent Posts
See AllThis week, the WHO recommended four new treatments for patients with MDR-TB. Three of the regimens were from the End TB trial, and one...
130
The Health Justice Initiative in South Africa has reported that the South African government is utilizing the Competition Act to...
290
Johnson and Johnson successfully applied for a patent extension on bedaquiline; however, in a big win for LMI countries, the company has...
200
bottom of page
Comments